Literature DB >> 4707988

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

W R Martin, D R Jasinski, P A Mansky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4707988     DOI: 10.1001/archpsyc.1973.01750360022003

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  49 in total

1.  Maintenance of reinforcement to address the chronic nature of drug addiction.

Authors:  Kenneth Silverman; Anthony DeFulio; Sigurdur O Sigurdsson
Journal:  Prev Med       Date:  2012-06-05       Impact factor: 4.018

2.  Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course.

Authors:  George E Bigelow; Kenzie L Preston; John Schmittner; Qunming Dong; David R Gastfriend
Journal:  Drug Alcohol Depend       Date:  2011-11-12       Impact factor: 4.492

Review 3.  Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.

Authors:  Stacey C Sigmon; Adam Bisaga; Edward V Nunes; Patrick G O'Connor; Thomas Kosten; George Woody
Journal:  Am J Drug Alcohol Abuse       Date:  2012-03-12       Impact factor: 3.829

Review 4.  Rational development of addiction pharmacotherapies: successes, failures, and prospects.

Authors:  R Christopher Pierce; Charles P O'Brien; Paul J Kenny; Louk J M J Vanderschuren
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 5.  Clinical safety of 1500 mg oral naltrexone overdose.

Authors:  Albert Stuart Reece
Journal:  BMJ Case Rep       Date:  2010-09-07

6.  Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin.

Authors:  Maria A Sullivan; Suzanne K Vosburg; Sandra D Comer
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

Review 7.  Oral naltrexone maintenance treatment for opioid dependence.

Authors:  Silvia Minozzi; Laura Amato; Simona Vecchi; Marina Davoli; Ursula Kirchmayer; Annette Verster
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

8.  Drugs, HIV, and prisons.

Authors: 
Journal:  BMJ       Date:  1991-08-10

9.  Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.

Authors:  S M Crain; K F Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.

Authors:  H E Shannon; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.